What are Analysts opinions on: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)


Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) will report its next earnings on Nov 10 – Nov 14 (Est.). The company reported the earnings of $-0.13/Share in the last quarter where the estimated EPS by analysts was $-0.13/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Immune Pharmaceuticals, Inc. and for the current quarter 2 analysts have projected that the stock could give an Average Earnings estimate of $-0.14/share. These analysts have also projected a Low Estimate of $-0.14/share and a High Estimate of $-0.13/share.

Some buy side analysts are also providing their Analysis on Immune Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 0 said it’s a HOLD, 0 reported it as Underperform and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. 2 Analysts reported that the Price Target for Immune Pharmaceuticals, Inc. might touch $3 high while the Average Price Target and Low price Target is $2 and $1 respectively.

To analyze a stock, one should look for Upgrades and Downgrades of a stock. Immune Pharmaceuticals, Inc. got Initiated on 8-Oct-15 where investment firm ROTH Capital Initiated the stock to Buy.

Immune Pharmaceuticals, Inc. closed its last trading session at $0.24 with the loss of -1.24%. The Market Capitalization of the company stands at 22.38 Million. The Company has 52-week high of $1.54 and 52-week low of $0.2. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -9.99% where SMA50 and SMA200 are -26.38% and -42.06% respectively. The Company Touched its 52-Week High on Nov 9, 2015 and 52-Week Low on May 27, 2016.

The Relative Volume of the company is 0.46 and Average Volume (3 months) is 3.23 million. Immune Pharmaceuticals, Inc. P/E (price to earnings) ratio is 0 and Forward P/E ratio of 9.6.

The company shows its Return on Assets (ROA) value of -83.1%. The Return on Equity (ROE) value stands at -389.6%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Immune Pharmaceuticals, Inc. currently shows a Weekly Performance of -4.04%, where Monthly Performance is -23.43%, Quarterly performance is -40.03%, 6 Months performance is -42.88% and yearly performance percentage is -81.96%. Year to Date performance value (YTD perf) value is -67.14%. The Stock currently has a Weekly Volatility of 10.60% and Monthly Volatility of 9.25%.